Zacks Investment Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
FAM
AIM
MCMC
CC
Zacks Investment Management's CDNA Position: Q3 2021 in Review
Zacks Investment Management sold out of CareDx (CDNA) in Q3 2021, closing a stake of 15,949 shares — an estimated $1.46M sold.
Zacks Investment Management first reported a position in CDNA in Q4 2019 and held it in 7 quarters. The position peaked at $3.23M in Q4 2020. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.
- Zacks Investment Management reported no remaining CareDx position as of Q3 2021 after selling out during the quarter.
- Zacks Investment Management sold 15,949 CareDx shares in Q3 2021, an estimated $1.46M.
- Zacks Investment Management first reported a position in CareDx in Q4 2019 and held it in 7 quarters.
- Zacks Investment Management's CareDx position peaked at $3.23M in Q4 2020.
- 260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.
Based on Zacks Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.